Suk-Joon Chang

30PUBLICATIONS
125CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsPharmaceutical delivery technologiesOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Feb 03, 2025
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines.

Banghyun Lee, Suk-Joon Chang, Byung Su Kwon

|Dec 04, 2024
Minimally invasive surgery versus open surgery in advanced stage endometrial cancer.

Jimin Lee, Jeeyeon Kim, Joo-Hyuk Son

|Aug 20, 2024
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11).

Hyun-Woong Cho, Hee-Seung Kim, Jeong-Yeol Park

Pageof 5